Tidal Investments LLC grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 7.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,369 shares of the medical device company’s stock after purchasing an additional 1,043 shares during the quarter. Tidal Investments LLC’s holdings in Cooper Companies were worth $1,585,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Cooper Companies by 2.8% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 6,797 shares of the medical device company’s stock worth $593,000 after acquiring an additional 184 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Cooper Companies by 112.7% in the second quarter. Blue Trust Inc. now owns 553 shares of the medical device company’s stock worth $48,000 after acquiring an additional 293 shares in the last quarter. First Horizon Advisors Inc. lifted its stake in shares of Cooper Companies by 4.8% in the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock worth $236,000 after acquiring an additional 125 shares in the last quarter. Fifth Third Bancorp lifted its stake in shares of Cooper Companies by 6.3% in the second quarter. Fifth Third Bancorp now owns 8,465 shares of the medical device company’s stock worth $739,000 after acquiring an additional 502 shares in the last quarter. Finally, &PARTNERS acquired a new position in shares of Cooper Companies in the second quarter worth about $827,000. Institutional investors and hedge funds own 24.39% of the company’s stock.
Insiders Place Their Bets
In other news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. This represents a 41.03 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.00% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on Cooper Companies
Cooper Companies Stock Performance
COO opened at $94.49 on Wednesday. The company has a market capitalization of $18.86 billion, a price-to-earnings ratio of 48.46, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The business has a 50 day moving average price of $103.04 and a two-hundred day moving average price of $99.00.
Cooper Companies (NASDAQ:COO – Get Free Report) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.87 earnings per share. Research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.
About Cooper Companies
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More
- Five stocks we like better than Cooper Companies
- What Does a Stock Split Mean?
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- What is the Nasdaq? Complete Overview with History
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- What is the Euro STOXX 50 Index?
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.